SEARCH Ends Badly For Simvastatin 80 Mg; FDA Restricts Use To Existing Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
New clinical trial data and adverse event reports show high-dose simvastatin-containing products have a greater risk for muscle toxicity than other statins, the agency concludes.